| Dr Thomas W Snickenberger, MD | |
|
1501 S California Ave, Chicago, IL 60608-1732 | |
| (773) 257-6663 | |
| Not Available |
| Full Name | Dr Thomas W Snickenberger |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1501 S California Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083698252 | NPI | - | NPPES |
| 036-062455-1 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas W Snickenberger, MD 3537 Paysphere Cir, Chicago, IL 60674-0035 Ph: (708) 786-2900 | Dr Thomas W Snickenberger, MD 1501 S California Ave, Chicago, IL 60608-1732 Ph: (773) 257-6663 |
News Archive
In a 15-year study of older Medicare patients, Yale School of Medicine researchers saw an estimated 20% drop in mortality, about 30% fewer hospitalizations, and 40% reduction in deaths after hospitalization.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has elected to fully exercise its current right to purchase 55,223 unregistered shares of Alnylam's common stock in accordance with the terms of the Investor Rights Agreement between Alnylam and Novartis, dated September 6, 2005.
"Robust" is an adjective appreciatively applied to certain vintage wines, but when describing viruses and pathogens, robustness is a property that may be much less desirable. It evokes drug resistant microbes and other superbugs that can wreak havoc as researchers struggle to deal with new pandemics. How can we undercut this robustness?
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 2 days ago
Dr. Yi-loong Colin Woon, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Dr. Vehniah Kristin Tjong, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St, 13th Floor, Chicago, IL 60611 Phone: 312-695-6800 | |
David R Guelich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 Halsted Street, Suite 525, Chicago, IL 60657 Phone: 773-443-3130 | |
Dr. Daniel A Ivankovich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1044 N Francisco Ave Ste 203, Chicago, IL 60622 Phone: 312-527-6500 Fax: 800-281-6952 | |
Dr. Michael R Treister, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1431 N Western Ave, Chicago, IL 60622 Phone: 312-633-5866 Fax: 312-633-5867 | |
Dr. Adam Isaac Edelstein, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 13-205, Chicago, IL 60611 Phone: 312-695-8143 Fax: 312-695-4075 | |
Dr. Ari J Kaz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2923 N California Ave, Suite 300, Chicago, IL 60618 Phone: 773-777-9900 Fax: 773-777-5927 |